NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

數位療法的全球市場

Digital Therapeutics

出版商 Global Industry Analysts, Inc. 商品編碼 903083
出版日期 內容資訊 英文 205 Pages
商品交期: 最快1-2個工作天內
價格
數位療法的全球市場 Digital Therapeutics
出版日期: 2021年05月01日內容資訊: 英文 205 Pages
簡介

本報告提供全球數位療法市場調查,提供市場概要,各市場區隔·地區的市場規模的變化與預測,市場趨勢及成長要素分析,競爭情形,主要企業的簡介等全面性資訊。

第1章 調查手法

第2章 摘要整理

  • 市場概要
    • 競爭企業的市場佔有率
    • 競爭企業的市場佔有率:方案
  • 關注企業
  • 市場趨勢和成長要素
  • 全球市場預測

第3章 市場分析

  • 地區市場分析
  • 美國
    • 概要
    • 企業的市場佔有率
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 其他歐洲各國
  • 亞太地區
  • 其他地區

第4章 競爭情形

  • 2MORROW, INC.
  • CANARY HEALTH
  • GINGER.IO
  • LIVONGO HEALTH
  • MANGO HEALTH
  • NOOM INC.
  • OMADA HEALTH, INC.
  • PROPELLER HEALTH
  • PROTEUS DIGITAL HEALTH, INC.
  • WELLDOC

第5章 調查資料

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP11567

Abstract:

Global Digital Therapeutics Market to Reach US$1.6 Billion by the Year 2027

Amid the COVID-19 crisis, the global market for Digital Therapeutics estimated at US$347.2 Million in the year 2020, is projected to reach a revised size of US$1.6 Billion by 2027, growing at a CAGR of 24.6% over the period 2020-2027.Preventive, one of the segments analyzed in the report, is projected to grow at a 22.7% CAGR to reach US$421.2 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Treatment/Care segment is readjusted to a revised 25.3% CAGR for the next 7-year period. This segment currently accounts for a 71% share of the global Digital Therapeutics market.

The U.S. Accounts for Over 29.9% of Global Market Size in 2020, While China is Forecast to Grow at a 24.1% CAGR for the Period of 2020-2027

The Digital Therapeutics market in the U.S. is estimated at US$103.8 Million in the year 2020. The country currently accounts for a 29.9% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$282.8 Million in the year 2027 trailing a CAGR of 24.1% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 21.6% and 21.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 17.5% CAGR while Rest of European market (as defined in the study) will reach US$282.8 Million by the year 2027.

Select Competitors (Total 56 Featured) -

  • Canary Health, Inc.
  • Dthera Sciences
  • Fitbit Health Solutions
  • Livongo Health, Inc.
  • Medtronic, Plc
  • Omada Health, Inc.
  • Propeller Health
  • Pear Therapeutics, Inc.
  • Proteus Digital Health, Inc.
  • WellDoc, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Impact of Covid-19 and a Looming Global Recession
    • Digital Therapeutics: An Introduction
    • Outlook
    • Leading Markets
    • Factors Impeding Growth
  • 2. FOCUS ON SELECT PLAYERS
    • Canary Health, Inc. (USA)
    • Dthera Sciences (USA)
    • Fitbit Health Solutions (USA
    • Livongo Health, Inc. (USA)
    • Medtronic, Plc (Ireland)
    • Omada Health, Inc. (USA)
    • Propeller Health (USA)
    • Pear Therapeutics, Inc. (USA)
    • Proteus Digital Health, Inc. (USA)
    • WellDoc, Inc. (USA)
  • 3. MARKET TRENDS & DRIVERS
    • Digital Therapeutics Continue to Attract Venture Capital Investments
    • EXHIBIT 1: Total Venture Capital Funding and Number of Deals in Digital Health Space: 2011-2018
    • EXHIBIT 2: Digital Health Funding by Segment (in US$ Million): 9M 2019
    • Startups Flock the Digital Therapeutics Market
    • Select Digital Therapeutics Startups
    • Digital Health Unicorn Startups
    • EXHIBIT 3: Quarterly Investments by Digital Therapeutics Startups in US$ Million: Q1 2018 to Q2 2019
    • Pipeline Products Drive Growth Prospects
    • A Snapshot of Select DTx Pipeline Products
    • Pharma Majors Foray into Uncharted Territory
    • Pharmaceutical Companies Team Up with Payers to Seek Reimbursement
    • Growing Focus on Preventative Healthcare Widens Growth Opportunities
    • Overcoming the Stigma of Mental Health through Digital Therapeutics
    • Global Number of People Suffering from Mental Disorders (In Million)
    • Growing Prevalence of Chronic Diseases to Boost Market Growth
    • EXHIBIT 4: Worldwide Prevalence of Diabetes: Number of Adults (20-79) with Diabetes (in Millions) by Region for 2017 and 2045
    • EXHIBIT 5: Global Annual Medical Cost of CVD in US$ Billion (2010-2030)
    • Global Obesity Epidemic: Percentage of Overweight, Obese, and Severely Obese Adults for 2014 & 2025
    • Digital Therpeutics in Oncology
    • Proliferation of Smart Devices Bodes Well for Market Growth
    • EXHIBIT 6: Smartphone Penetration (as a Proportion of Total Mobile Users) by Region for the Years 2018 and 2025
    • EXHIBIT 7: United States Mobile Health Apps Market by Type (in %): 2018 & 2025
    • Growing Focus on Reducing Healthcare Costs Bolsters Market Growth
    • EXHIBIT 8: Global Healthcare Expenditure (In US$ Trillion) for the Years 2017, 2019, and 2022
    • Aging Population and their Vulnerability to Various Health Conditions: A Vital Growth Driver
    • EXHIBIT 9: Global Population for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Digital Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 2: World 7-Year Perspective for Digital Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
    • TABLE 3: World Current & Future Analysis for Preventive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 4: World 7-Year Perspective for Preventive by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 5: World Current & Future Analysis for Treatment/Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 6: World 7-Year Perspective for Treatment/Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 7: World Current & Future Analysis for B2C by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 8: World 7-Year Perspective for B2C by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 9: World Current & Future Analysis for B2B by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 10: World 7-Year Perspective for B2B by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 11: USA Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 12: USA 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
    • TABLE 13: USA Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 14: USA 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
  • CANADA
    • TABLE 15: Canada Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 16: Canada 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
    • TABLE 17: Canada Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 18: Canada 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
  • JAPAN
    • TABLE 19: Japan Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 20: Japan 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
    • TABLE 21: Japan Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 22: Japan 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
  • CHINA
    • TABLE 23: China Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 24: China 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
    • TABLE 25: China Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 26: China 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
  • EUROPE
    • TABLE 27: Europe Current & Future Analysis for Digital Therapeutics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 28: Europe 7-Year Perspective for Digital Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
    • TABLE 29: Europe Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 30: Europe 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
    • TABLE 31: Europe Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 32: Europe 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
  • FRANCE
    • TABLE 33: France Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 34: France 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
    • TABLE 35: France Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 36: France 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
  • GERMANY
    • TABLE 37: Germany Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 38: Germany 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
    • TABLE 39: Germany Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 40: Germany 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
  • ITALY
    • TABLE 41: Italy Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 42: Italy 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
    • TABLE 43: Italy Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 44: Italy 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
  • UNITED KINGDOM
    • TABLE 45: UK Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 46: UK 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
    • TABLE 47: UK Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 48: UK 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
  • REST OF EUROPE
    • TABLE 49: Rest of Europe Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 50: Rest of Europe 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
    • TABLE 51: Rest of Europe Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 52: Rest of Europe 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 53: Asia-Pacific Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 54: Asia-Pacific 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
    • TABLE 55: Asia-Pacific Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Asia-Pacific 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
  • REST OF WORLD
    • TABLE 57: Rest of World Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 58: Rest of World 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
    • TABLE 59: Rest of World Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 60: Rest of World 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 56